Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).
This study has been completed.
Study NCT00430534 Information provided by Henogen
First Received on February 1, 2007. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epstein Barr Virus (EBV) Infection
Interventions listed in this trial
EBV vaccine (268664)
Sponsors listed in this trial
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers